首页> 美国卫生研究院文献>Scientific Reports >Performance of Cystatin C-Based Equations for Estimation of Glomerular Filtration Rate in Diabetes Patients: A Prisma-Compliant Systematic Review and Meta-Analysis
【2h】

Performance of Cystatin C-Based Equations for Estimation of Glomerular Filtration Rate in Diabetes Patients: A Prisma-Compliant Systematic Review and Meta-Analysis

机译:基于胱抑素C的糖尿病患者肾小球滤过率评估方程的性能:符合棱镜的系统评价和荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The accuracy of estimated glomerular filtration rate (eGFR) equations in diabetes mellitus (DM) patients has been extensively questioned. We evaluated the performance of cystatin C-based equations alone or in combination with creatinine to estimate GFR in DM patients. A PRISMA-compliant systematic review was performed in the MEDLINE and Embase databases, with “diabetes mellitus” and “cystatin C” as search terms. Studies comparing cystatin C-based eGFR equations with measured GFR (mGFR) in DM patients were eligible. Accuracies P10, P15, P20, and P30 indicated the proportion of eGFR results within 10, 15, 20, and 30% of mGFR. Single-arm meta-analyses were conducted, and the Quality of Diagnostic Accuracy Studies-II tool (QUADAS-2) was applied. Twenty-three studies comprising 7065 participants were included, and 24 equations were analyzed in a broad range of GFRs. Meta-analyses were completed for 10 equations. The mean P30 accuracies of the equations ranged from 41% to 87%, with the highest values found with both CKD-EPI equations. Mean P10-P15 achieved 35% in the best scenario. A sensitivity analysis to evaluate different mGFR methods did not change results. In conclusion, cystatin C-based eGFR equations represent measured GFR fairly at best in DM patients, with high variability among the several proposed equations.
机译:糖尿病(DM)患者中估计的肾小球滤过率(eGFR)方程的准确性已受到广泛质疑。我们评估了单独或与肌酐联合使用基于胱抑素C的方程式的性能,以评估DM患者的GFR。在MEDLINE和Embase数据库中进行了符合PRISMA的系统评价,以“糖尿病”和“胱抑素C”作为搜索词。将DM患者中基于胱抑素C的eGFR方程与测得的GFR(mGFR)进行比较的研究是合格的。准确度P10,P15,P20和P30表示eGFR结果的比例在mGFR的10%,15%,20%和30%之内。进行了单臂荟萃分析,并应用了诊断准确性研究II工具(QUADAS-2)的质量。包括7065名参与者的23项研究包括在内,并在广泛的GFR中分析了24个方程。荟萃分析完成了10个方程式。这些方程式的平均P30精度范围从41%到87%,在两个CKD-EPI方程式中都发现了最高值。在最佳情况下,平均P10-P15达到35%。评估不同mGFR方法的敏感性分析未改变结果。总之,基于胱抑素C的eGFR方程充其量可以很好地代表DM患者的GFR,在几个提议的方程之间差异很大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号